US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BioAge Labs Inc.

17.85

+3.8227.23%

Post-market: 17.950.1000+0.56%19:45 EST

Volume:1.90M

Turnover:31.66M

Market Cap:640.01M

PE:-8.45

High:17.90

Open:15.00

Low:14.91

Close:14.03

52wk High:17.90

52wk Low:2.88

Shares:35.86M

Float Shares:24.31M

Volume Ratio:1.75

T/O Rate:7.82%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.1117

EPS(LYR):-6.6293

ROE:-25.64%

ROA:-17.46%

PB:2.31

PE(LYR):-2.69

Loading ...

Overview Company News Filings

Calendar of U.S. Earnings Expected in the Week Ahead

BIOAGE Labs Inc expected to post a loss of 58 cents a share - Earnings Preview

BioAge Labs Is Maintained at Buy by Citigroup

U.S. RESEARCH ROUNDUP-Avery Dennison, Expedia Group, Hologic

BioAge Labs Shares Rise After Citigroup Upgrade

MT Newswires Live

BioAge Labs Raised to Buy From Neutral by Citigroup

Bioage Labs Shares Jump 7.7% Premarket After Citigroup Upgrade, PT Hike

THOMSON REUTERS

BioAge Labs upgraded to Buy from Neutral at Citi

BRIEF-BioAge Labs Files For Mixed Shelf Offering Of Up To $250 Million - SEC Filing

BioAge Labs Files $250 Million Mixed Shelf

MT Newswires Live

BioAge Labs files $250M mixed securities shelf

Bioage Labs Inc : Files for Mixed Shelf Offering of up to $250 Mln - SEC Filing

THOMSON REUTERS

BioAge Labs, Inc. (NASDAQ:BIOA) institutional owners may be pleased with recent gains after 74% loss over the past year

Simply Wall St.

BioAge Labs Inc. to Participate in Citi's 2025 Biopharma Back to School Conference

BioAge Labs Initiates Phase 1 Clinical Trial for BGE-102, a Brain-Penetrant NLRP3 Inhibitor Targeting Obesity

Bioage Labs Inc - Phase 1 Sad Data for Bge-102 by End of 2025

THOMSON REUTERS

Bioage Labs Announces First Participant Dosed in Phase 1 Clinical Trial of Bge-102, a Novel Brain-Penetrant Nlrp3 Inhibitor

THOMSON REUTERS

Bioage Labs Q2 EPS $(0.60) Misses $(0.45) Estimate

BioAge Labs Reports Q2 2025 Financial Results: R&D Expenses Rise by $9.3 Million Due to APJ Agonist and BGE-102 Programs

BioAge Labs Reports Second Quarter 2025 Financial Results and Provides Business Updates

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BIOA/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BIOA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIOA\",,,,,undefined,":{"symbol":"BIOA","market":"US","secType":"STK","nameCN":"BioAge Labs Inc.","latestPrice":17.85,"timestamp":1768251600000,"preClose":14.03,"halted":0,"volume":1901934,"hourTrading":{"tag":"盘后","latestPrice":17.95,"preClose":17.85,"latestTime":"19:45 EST","volume":10537,"amount":188451.7287,"timestamp":1768265103025},"delay":0,"floatShares":24308899,"shares":35855037,"eps":-2.111699,"marketStatus":"Not Yet Opened","change":3.82,"latestTime":"01-12 16:00:00 EST","open":15,"high":17.9,"low":14.905,"amount":31660753.543739997,"amplitude":0.213471,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.111699,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1768294800000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1727323200000,"exchange":"NASDAQ","adjPreClose":14.03,"preHourTrading":{"tag":"盘前","latestPrice":15.15,"preClose":14.03,"latestTime":"09:28 EST","volume":6981,"amount":100883.457207,"timestamp":1768228080436},"postHourTrading":{"tag":"盘后","latestPrice":17.95,"preClose":17.85,"latestTime":"19:45 EST","volume":10537,"amount":188451.7287,"timestamp":1768265103025},"volumeRatio":1.7476,"impliedVol":0.5765,"impliedVolPercentile":0.313},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIOA\",,,,,undefined,":{"symbol":"BIOA","floatShares":24308899,"roa":"-17.46%","roe":"-25.64%","lyrEps":-6.629269,"volumeRatio":1.7476,"shares":35855037,"dividePrice":0,"high":17.9,"amplitude":0.213471,"preClose":14.03,"low":14.905,"week52Low":2.88,"pbRate":"2.31","psRate":"108.17","week52High":17.9,"institutionHeld":0,"latestPrice":17.85,"eps":-2.111699,"divideRate":0,"volume":1901934,"delay":0,"ttmEps":-2.111699,"open":15,"prevYearClose":13.23,"prevWeekClose":14.03,"prevMonthClose":13.23,"prevQuarterClose":13.23,"fiveDayClose":12.62,"twentyDayClose":12.75,"sixtyDayClose":5.69},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIOA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-06","symbol":"BIOA","fiscalQuarterEnding":"2025/09","expectedEps":-0.67,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":-0.56},{"market":"US","date":"2025-08-06","symbol":"BIOA","fiscalQuarterEnding":"2025/06","expectedEps":-0.56,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":-0.6},{"market":"US","date":"2025-05-06","symbol":"BIOA","fiscalQuarterEnding":"2025/03","expectedEps":-0.52,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746504000000,"reportTimeType":"post","actualEps":-0.36},{"date":"2025-03-20","symbol":"BIOA","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2024/12","expectedEps":-0.58,"defaultRemindTime":1742500800000,"name":null,"time":"Post Market","dateTimestamp":1742443200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIOA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BIOA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0,"hold":0.75,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0,"analysts":4,"updateTime":1765170000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BIOA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BIOA","date":"2026-01-09","current":-8.452909,"percent":0.173913,"low":-14.88445,"twenty":-6.05445,"median":-2.344838,"eighty":-2.11744,"high":-1.532635,"avg":-4.150286,"sd":3.439218,"marketCap":499102115},"quantilePoints":[{"date":"2024-09-27","current":-10.065016,"twenty":-9.996853,"median":-9.894609,"eighty":-9.328936,"marketCap":625601139},{"date":"2024-10-04","current":-11.466752,"twenty":-11.453559,"median":-10.988513,"eighty":-9.962772,"marketCap":712727458},{"date":"2024-10-11","current":-11.290848,"twenty":-11.83725,"median":-11.290848,"eighty":-10.377246,"marketCap":701793959},{"date":"2024-10-18","current":-13.247909,"twenty":-12.852074,"median":-11.505231,"eighty":-10.913754,"marketCap":823437060},{"date":"2024-10-25","current":-13.708907,"twenty":-13.699687,"median":-12.032944,"eighty":-11.062173,"marketCap":852090807},{"date":"2024-10-31","current":-14.198716,"twenty":-13.910593,"median":-12.258321,"eighty":-11.163318,"marketCap":882535413},{"date":"2024-11-08","current":-10.411209,"twenty":-13.841443,"median":-12.631325,"eighty":-11.163318,"marketCap":738550334},{"date":"2024-11-15","current":-9.850761,"twenty":-13.741177,"median":-12.203351,"eighty":-10.879672,"marketCap":698793259},{"date":"2024-11-22","current":-9.318711,"twenty":-13.704297,"median":-11.736106,"eighty":-10.071646,"marketCap":661050728},{"date":"2024-11-29","current":-9.500638,"twenty":-13.685857,"median":-11.456511,"eighty":-9.850761,"marketCap":673956274},{"date":"2024-12-06","current":-9.283336,"twenty":-13.657045,"median":-11.290848,"eighty":-9.500638,"marketCap":658541317},{"date":"2024-12-13","current":-2.319571,"twenty":-13.258776,"median":-11.073716,"eighty":-9.298497,"marketCap":164545707},{"date":"2024-12-20","current":-2.612676,"twenty":-13.247909,"median":-10.411209,"eighty":-9.141838,"marketCap":185337975},{"date":"2024-12-27","current":-2.971476,"twenty":-13.224859,"median":-10.152544,"eighty":-7.606575,"marketCap":210790579},{"date":"2025-01-03","current":-2.809763,"twenty":-13.09117,"median":-10.065016,"eighty":-3.032119,"marketCap":199318983},{"date":"2025-01-10","current":-2.572247,"twenty":-12.858367,"median":-9.894609,"eighty":-2.886577,"marketCap":182470076},{"date":"2025-01-17","current":-2.54698,"twenty":-12.632478,"median":-9.680039,"eighty":-2.714757,"marketCap":180677639},{"date":"2025-01-24","current":-2.678371,"twenty":-12.552115,"median":-9.568861,"eighty":-2.625815,"marketCap":189998311},{"date":"2025-01-31","current":-2.415588,"twenty":-12.247327,"median":-9.318711,"eighty":-2.600547,"marketCap":171356967},{"date":"2025-02-07","current":-2.309464,"twenty":-12.16927,"median":-9.263122,"eighty":-2.51868,"marketCap":163828732},{"date":"2025-02-14","current":-2.284196,"twenty":-12.012055,"median":-9.141838,"eighty":-2.417609,"marketCap":162036295},{"date":"2025-02-21","current":-2.223554,"twenty":-11.928501,"median":-8.818412,"eighty":-2.37516,"marketCap":157734447},{"date":"2025-02-28","current":-2.208393,"twenty":-11.54371,"median":-3.087708,"eighty":-2.319571,"marketCap":156658985},{"date":"2025-03-07","current":-2.269035,"twenty":-11.466752,"median":-2.971476,"eighty":-2.294303,"marketCap":160960833},{"date":"2025-03-14","current":-2.122483,"twenty":-11.446271,"median":-2.893147,"eighty":-2.269035,"marketCap":150564699},{"date":"2025-03-21","current":-2.208204,"twenty":-11.43377,"median":-2.779442,"eighty":-2.233661,"marketCap":157023162},{"date":"2025-03-28","current":-1.956126,"twenty":-11.290848,"median":-2.7188,"eighty":-2.233661,"marketCap":139098143},{"date":"2025-04-04","current":-1.714131,"twenty":-11.203915,"median":-2.693532,"eighty":-2.213447,"marketCap":121890125},{"date":"2025-04-11","current":-1.729255,"twenty":-11.131435,"median":-2.645523,"eighty":-2.198286,"marketCap":122965626},{"date":"2025-04-17","current":-1.890585,"twenty":-11.039085,"median":-2.589935,"eighty":-2.192221,"marketCap":134437638},{"date":"2025-04-25","current":-2.117456,"twenty":-10.879672,"median":-2.54698,"eighty":-2.170997,"marketCap":150570155},{"date":"2025-05-02","current":-2.087206,"twenty":-10.498085,"median":-2.486337,"eighty":-2.155781,"marketCap":148419153},{"date":"2025-05-09","current":-2.073948,"twenty":-10.229442,"median":-2.420641,"eighty":-2.117456,"marketCap":147343652},{"date":"2025-05-16","current":-1.927611,"twenty":-10.158835,"median":-2.377687,"eighty":-2.112406,"marketCap":136947141},{"date":"2025-05-23","current":-2.038626,"twenty":-10.109042,"median":-2.344838,"eighty":-2.086198,"marketCap":144834149},{"date":"2025-05-30","current":-2.008349,"twenty":-10.078276,"median":-2.334731,"eighty":-2.073148,"marketCap":142683147},{"date":"2025-06-06","current":-2.24047,"twenty":-9.99928,"median":-2.314518,"eighty":-2.051746,"marketCap":159174164},{"date":"2025-06-13","current":-2.2657,"twenty":-9.918948,"median":-2.294303,"eighty":-2.064674,"marketCap":160966666},{"date":"2025-06-20","current":-2.215239,"twenty":-9.87707,"median":-2.284196,"eighty":-2.072748,"marketCap":157381662},{"date":"2025-06-27","current":-2.200101,"twenty":-9.785504,"median":-2.271562,"eighty":-2.073948,"marketCap":156306161},{"date":"2025-07-03","current":-2.159732,"twenty":-9.684587,"median":-2.26468,"eighty":-2.075591,"marketCap":153438158},{"date":"2025-07-11","current":-2.361576,"twenty":-9.665383,"median":-2.263661,"eighty":-2.08254,"marketCap":167778173},{"date":"2025-07-18","current":-2.422129,"twenty":-9.609795,"median":-2.271562,"eighty":-2.08404,"marketCap":172080177},{"date":"2025-07-25","current":-2.371668,"twenty":-9.500638,"median":-2.280838,"eighty":-2.084673,"marketCap":168495173},{"date":"2025-08-01","current":-2.220285,"twenty":-9.464253,"median":-2.280838,"eighty":-2.088197,"marketCap":157740162},{"date":"2025-08-08","current":-1.959737,"twenty":-9.314668,"median":-2.269035,"eighty":-2.084673,"marketCap":154872159},{"date":"2025-08-15","current":-2.023247,"twenty":-9.295465,"median":-2.262157,"eighty":-2.074957,"marketCap":159891165},{"date":"2025-08-22","current":-2.041393,"twenty":-9.27525,"median":-2.258928,"eighty":-2.064982,"marketCap":161325166},{"date":"2025-08-29","current":-2.177486,"twenty":-9.225726,"median":-2.244642,"eighty":-2.064982,"marketCap":172080177},{"date":"2025-09-05","current":-2.136658,"twenty":-9.156998,"median":-2.24047,"eighty":-2.068612,"marketCap":168853674},{"date":"2025-09-12","current":-2.227387,"twenty":-9.141838,"median":-2.24047,"eighty":-2.071948,"marketCap":176023681},{"date":"2025-09-19","current":-2.368016,"twenty":-8.95182,"median":-2.24047,"eighty":-2.073948,"marketCap":187137193},{"date":"2025-09-26","current":-2.368016,"twenty":-8.818412,"median":-2.24047,"eighty":-2.073948,"marketCap":187137193},{"date":"2025-10-03","current":-2.676493,"twenty":-8.732502,"median":-2.244642,"eighty":-2.078994,"marketCap":211515218},{"date":"2025-10-10","current":-2.472354,"twenty":-3.102868,"median":-2.258928,"eighty":-2.082165,"marketCap":195382701},{"date":"2025-10-17","current":-2.318115,"twenty":-3.072547,"median":-2.260654,"eighty":-2.08404,"marketCap":183193689},{"date":"2025-10-24","current":-3.606461,"twenty":-3.072547,"median":-2.2657,"eighty":-2.08404,"marketCap":285007794},{"date":"2025-10-31","current":-3.50666,"twenty":-3.483977,"median":-2.271562,"eighty":-2.087206,"marketCap":277120786},{"date":"2025-11-07","current":-3.533398,"twenty":-3.483977,"median":-2.280838,"eighty":-2.091294,"marketCap":267799776},{"date":"2025-11-14","current":-3.65216,"twenty":-3.543352,"median":-2.287377,"eighty":-2.091294,"marketCap":276800885},{"date":"2025-11-21","current":-4.063738,"twenty":-3.690007,"median":-2.299357,"eighty":-2.092162,"marketCap":307994767},{"date":"2025-11-28","current":-4.489508,"twenty":-3.899107,"median":-2.309042,"eighty":-2.092231,"marketCap":340264301},{"date":"2025-12-05","current":-4.967317,"twenty":-4.069415,"median":-2.318115,"eighty":-2.105866,"marketCap":376477888},{"date":"2025-12-12","current":-6.031742,"twenty":-4.3315,"median":-2.319571,"eighty":-2.109405,"marketCap":457151721},{"date":"2025-12-19","current":-5.856703,"twenty":-5.07234,"median":-2.333015,"eighty":-2.111789,"marketCap":443885358},{"date":"2025-12-26","current":-6.660935,"twenty":-5.750734,"median":-2.336346,"eighty":-2.112399,"marketCap":504838920},{"date":"2026-01-02","current":-6.258819,"twenty":-5.908741,"median":-2.336346,"eighty":-2.11442,"marketCap":474362139},{"date":"2026-01-09","current":-6.585243,"twenty":-6.05445,"median":-2.344838,"eighty":-2.11744,"marketCap":499102115}],"updateTime":1768270603915},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BIOA\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2581065756","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2581065756","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581065756?lang=en_us&edition=fundamental","pubTime":"2025-11-06 19:00","pubTimestamp":1762426800,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·A-Mark Precs Mtl                                1Q       .60    4:05 PM. ·Achve Life Scncs                                3Q      (.24)   7:30 AM. ·Air Pdts and Chem                                4Q      3.38    6:00 AM. ·Alpha Metall Rsrcs                               3Q      (.52)   7:30 AM. ·Altice USA Inc.                                 3Q      (.06)   7:00 AM","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CARL","ALG","ALTG","AORT","BIOA","ABNB","ASTH","OPTU","AMN","APYX","AURA","AMLX","ADV","ACRV","APD","AMPH","APLT","ASPN","ABCL","ATHM","APPN","ALRM","AAON","ABL","ALT","AGO","ACHV","GOOS","AAOI","AKAM","ATUS","ARLO","BIRD","ADVM","AMR","ASMB","AMTX","BLZE","AHR","ACIW","ARHS","AVAH","AEE","AFRM","ATYR","ALLO","AMRK","ATLC","AMBQ","AMPX"],"gpt_icon":1},{"id":"2581354701","title":"BIOAGE Labs Inc  expected to post a loss of 58 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2581354701","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581354701?lang=en_us&edition=fundamental","pubTime":"2025-11-06 05:06","pubTimestamp":1762376782,"startTime":"0","endTime":"0","summary":"BIOAGE Labs Inc  expected to post a loss of58cents a share - Earnings Preview BIOAGE Labs Inc BIOA.OQ BIOA.O is expected to  show a rise in quarterly revenue when it reports  results on November 7 (es","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nL8N3WH379:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BIOA"],"gpt_icon":0},{"id":"2579557133","title":"BioAge Labs Is Maintained at Buy by Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2579557133","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579557133?lang=en_us&edition=fundamental","pubTime":"2025-10-30 04:06","pubTimestamp":1761768360,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BIOA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 29, 2025 16:06 ET (20:06 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA"],"gpt_icon":0},{"id":"2577666373","title":"U.S. RESEARCH ROUNDUP-Avery Dennison, Expedia Group, Hologic","url":"https://stock-news.laohu8.com/highlight/detail?id=2577666373","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577666373?lang=en_us&edition=fundamental","pubTime":"2025-10-23 15:30","pubTimestamp":1761204653,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Avery Dennison, Expedia Group, Hologic Oct 23 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Aver","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251023:nL8N3W40G6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GEV","CME","LU1815336760.USD","BKNG","GPOR","MRNA","RL","BK4150","OFG","APH","FULT","HLT","NRIX","NTRS","DECK","FI","IDYA","GSHD","IE00BZ1G4Q59.USD","MOS","LU2023250504.SGD","LRCX","CPRI","GPC","IE00BJJMRZ35.SGD","LU0477156797.USD","MBCN","LU1861217088.USD","CBU","CCI","LU2357125470.USD","DKNG","KREF","BHB","ELV","LC","JAZZ","LU2023250843.SGD","BSX","AVY","LU2125909247.SGD","ARCT","FRPT","ALKS","HOLX","T","LVS","EXPE","BIOA","LII"],"gpt_icon":0},{"id":"2577986318","title":"BioAge Labs Shares Rise After Citigroup Upgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=2577986318","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577986318?lang=en_us&edition=fundamental","pubTime":"2025-10-23 02:39","pubTimestamp":1761158351,"startTime":"0","endTime":"0","summary":"BioAge Labs  shares were up over 13% in recent Wednesday trading after Citigroup upgraded the stock to buy from neutral and boosted its price target to $10 from $5.Trading volume stood at more than 1.0 million shares, compared with a daily average of about 167,000.Price: 6.00, Change: +0.70, Percent Change: +13.21","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BIOA"],"gpt_icon":0},{"id":"2577910366","title":"BioAge Labs Raised to Buy From Neutral by Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2577910366","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577910366?lang=en_us&edition=fundamental","pubTime":"2025-10-22 19:31","pubTimestamp":1761132660,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BIOA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 22, 2025 07:31 ET (11:31 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA"],"gpt_icon":0},{"id":"2577350984","title":"Bioage Labs Shares Jump 7.7% Premarket After Citigroup Upgrade, PT Hike","url":"https://stock-news.laohu8.com/highlight/detail?id=2577350984","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577350984?lang=en_us&edition=fundamental","pubTime":"2025-10-22 18:14","pubTimestamp":1761128095,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251022:nFWN3W228J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BIOA"],"gpt_icon":0},{"id":"2577354044","title":"BioAge Labs upgraded to Buy from Neutral at Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2577354044","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577354044?lang=en_us&edition=fundamental","pubTime":"2025-10-22 17:10","pubTimestamp":1761124209,"startTime":"0","endTime":"0","summary":"Citi upgraded BioAge Labs (BIOA) to Buy from Neutral with a price target of $10, up from $5. The firm believes the company’s BGE-102 can become a “...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bioage-labs-upgraded-to-buy-from-neutral-at-citi-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bioage-labs-upgraded-to-buy-from-neutral-at-citi-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIOA"],"gpt_icon":0},{"id":"2572526624","title":"BRIEF-BioAge Labs Files For Mixed Shelf Offering Of Up To $250 Million - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2572526624","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572526624?lang=en_us&edition=fundamental","pubTime":"2025-10-03 05:58","pubTimestamp":1759442280,"startTime":"0","endTime":"0","summary":"BRIEF-BioAge Labs Files For Mixed Shelf Offering Of Up To $250 Million - SEC FilingOct 2  - BIOAGE Labs Inc BIOA.O:BIOAGE LABS INC : FILES FOR MIXED SHELF OFFERING OF UP TO $250 MILLION - SEC FILINGSource text: [ID:n0001193125-25-228414]Further company coverage: BIOA.O ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251002:nFWN3VJ0H9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BIOA"],"gpt_icon":0},{"id":"2572250535","title":"BioAge Labs Files $250 Million Mixed Shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2572250535","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572250535?lang=en_us&edition=fundamental","pubTime":"2025-10-03 05:37","pubTimestamp":1759441036,"startTime":"0","endTime":"0","summary":"BioAge Labs  filed a registration statement Thursday for the potential sale of up to $250 million of securities from time to time in one or more offerings.The securities cover common and preferred stocks, debt securities, warrants, subscription rights, and units.Net proceeds will be used for general corporate purposes.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BIOA","BK4007"],"gpt_icon":0},{"id":"2572452394","title":"BioAge Labs files $250M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2572452394","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572452394?lang=en_us&edition=fundamental","pubTime":"2025-10-03 04:35","pubTimestamp":1759437307,"startTime":"0","endTime":"0","summary":"16:32 EDT BioAge Labs (BIOA) files $250M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving breaki...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bioage-labs-files-250m-mixed-securities-shelf-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bioage-labs-files-250m-mixed-securities-shelf-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BIOA"],"gpt_icon":0},{"id":"2572528000","title":"Bioage Labs Inc : Files for Mixed Shelf Offering of up to $250 Mln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2572528000","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572528000?lang=en_us&edition=fundamental","pubTime":"2025-10-03 04:31","pubTimestamp":1759437096,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251002:nFWN3VJ0H9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BIOA"],"gpt_icon":0},{"id":"2570899883","title":"BioAge Labs, Inc. (NASDAQ:BIOA) institutional owners may be pleased with recent gains after 74% loss over the past year","url":"https://stock-news.laohu8.com/highlight/detail?id=2570899883","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570899883?lang=en_us&edition=fundamental","pubTime":"2025-09-27 21:18","pubTimestamp":1758979096,"startTime":"0","endTime":"0","summary":"Key Insights Given the large stake in the stock by institutions, BioAge Labs' stock price might be vulnerable to their...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-bioa/bioage-labs/news/bioage-labs-inc-nasdaqbioa-institutional-owners-may-be-pleas","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-bioa/bioage-labs/news/bioage-labs-inc-nasdaqbioa-institutional-owners-may-be-pleas","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["NVIW.SI","TQQQ",".IXIC","MNQmain","BK4007","QQQ","PSQ","SQQQ","QID","NQmain","QLD","USJW.SI","BIOA","USAW.SI","TSYW.SI"],"gpt_icon":0},{"id":"2561481948","title":"BioAge Labs Inc. to Participate in Citi's 2025 Biopharma Back to School Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2561481948","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561481948?lang=en_us&edition=fundamental","pubTime":"2025-08-21 04:30","pubTimestamp":1755721813,"startTime":"0","endTime":"0","summary":"BioAge Labs, Inc., a clinical-stage biotechnology company focused on developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging, will participate in Citi's 2025 Biopharma Back to School Conference in Boston from September 2-3, 2025. CEO and co-founder Kristen Fortney, PhD, and CFO Dov Goldstein, MD, will participate in a fireside chat on September 3 from 3:15-3:55 PM EDT and engage in one-on-one meetings.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bioage Labs Inc. published the original content used to generate this news brief via GlobeNewswire  on August 20, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nNDLb8W6pN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1668664300.SGD","IE00BKPKM429.USD","LU2417539215.USD","LU1791807156.HKD","LU0130517989.USD","LU0130102774.USD","LU2125154935.USD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","BK4007","LU0052756011.USD","LU2236285917.USD","LU0162691827.USD","LU2456880835.USD","BK4559","BK4207","BK4504","IE00B64PRP62.GBP","LU1244550494.USD","LU0314104364.USD","LU1267930227.SGD","BK4585","LU1366192091.USD","LU2210150020.SGD","LU1162221912.USD","LU2360032135.SGD","BK4566","NDAQ","LU0106831901.USD","LU0320765646.SGD","BK4588","LU0098860793.USD","LU0128525689.USD","LU2210149790.SGD","LU1244550221.USD","LU2095319765.USD","LU2125154778.USD","LU0170899867.USD","LU0310800965.SGD","BIOA","LU1244550577.SGD","LU0072461881.USD","LU1201861249.SGD","BK4112","LU0648001328.SGD","LU2462157665.USD","IE00BSNM7G36.USD","LU0980610538.SGD","BK4534","LU0477156953.USD"],"gpt_icon":0},{"id":"2559149309","title":"BioAge Labs Initiates Phase 1 Clinical Trial for BGE-102, a Brain-Penetrant NLRP3 Inhibitor Targeting Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2559149309","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559149309?lang=en_us&edition=fundamental","pubTime":"2025-08-15 21:01","pubTimestamp":1755262886,"startTime":"0","endTime":"0","summary":"BioAge Labs Inc., a clinical-stage biotechnology company, has announced the commencement of a Phase 1 clinical trial for BGE-102, an innovative, orally available small molecule inhibitor of NLRP3. This novel inhibitor demonstrates potential for significant brain penetration and is initially being developed for obesity treatment. The study, which marks the first human dosing of BGE-102, aims to evaluate the drug's safety, tolerability, pharmacokinetics, and pharmacodynamics. Preclinical models have shown promising results, highlighting robust weight loss when BGE-102 is used as a monotherapy or in combination with GLP-1 receptor agonists. BioAge Labs anticipates initial data from the study's single ascending dose  phase by the end of 2025. The company plans to conduct a proof-of-concept study in 2026, with top-line results expected by the end of that year.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250815:nNDLvR2QQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","BIOA","LU0314104364.USD","NDAQ","BK4112","IE00B3QW5Z07.USD","LU2095319765.USD","LU2210149790.SGD","BK4007","IE00BKPKM429.USD","BK4585","BK4588"],"gpt_icon":0},{"id":"2559914941","title":"Bioage Labs Inc - Phase 1 Sad Data for Bge-102 by End of 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2559914941","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559914941?lang=en_us&edition=fundamental","pubTime":"2025-08-15 21:00","pubTimestamp":1755262800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250815:nTUA5WPTSJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BIOA","BK4007"],"gpt_icon":0},{"id":"2559591464","title":"Bioage Labs Announces First Participant Dosed in Phase 1 Clinical Trial of Bge-102, a Novel Brain-Penetrant Nlrp3 Inhibitor","url":"https://stock-news.laohu8.com/highlight/detail?id=2559591464","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559591464?lang=en_us&edition=fundamental","pubTime":"2025-08-15 21:00","pubTimestamp":1755262800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250815:nTUA5WPTSJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BIOA"],"gpt_icon":0},{"id":"2557300493","title":"Bioage Labs Q2 EPS $(0.60) Misses $(0.45) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2557300493","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557300493?lang=en_us&edition=fundamental","pubTime":"2025-08-07 05:13","pubTimestamp":1754514829,"startTime":"0","endTime":"0","summary":"Bioage Labs (NASDAQ:BIOA) reported quarterly losses of $(0.60) per share which missed the analyst consensus estimate of $(0.45) by 33.33 percent.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/46929491/bioage-labs-q2-eps-0-60-misses-0-45-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Bioage Labs Q2 EPS $(0.60) Misses $(0.45) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA"],"gpt_icon":0},{"id":"2557307232","title":"BioAge Labs Reports Q2 2025 Financial Results: R&D Expenses Rise by $9.3 Million Due to APJ Agonist and BGE-102 Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2557307232","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557307232?lang=en_us&edition=fundamental","pubTime":"2025-08-07 04:32","pubTimestamp":1754512346,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bioage Labs Inc. published the original content used to generate this news brief via GlobeNewswire  on August 06, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250806:nNDLx3k2g:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","BK4007","IE00B64PRP62.GBP","LU2210150020.SGD","LU2210149790.SGD","LU0314104364.USD","BK4585","IE00BGHQF748.EUR","BK4588","BIOA","BK4112","IE00BKPKM429.USD","LU2095319765.USD","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2557070333","title":"BioAge Labs Reports Second Quarter 2025 Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2557070333","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557070333?lang=en_us&edition=fundamental","pubTime":"2025-08-07 04:30","pubTimestamp":1754512200,"startTime":"0","endTime":"0","summary":"Oral NLRP3 inhibitor BGE-102 on track for Phase 1 initiation in 2H 2025 with initial data by year-end Expanded APJ agonist pipeline through option agreement for novel antibody and advancement of propr","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/06/3128733/0/en/BioAge-Labs-Reports-Second-Quarter-2025-Financial-Results-and-Provides-Business-Updates.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BIOA"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":40,"code":"91000000","status":"200"}]}}